MRK - Merck & Co., Inc.
119.83
-1.580 -1.319%
Share volume: 9,276,447
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$121.41
-1.58
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-03-2024 | 08-05-2024 | 11-06-2024 | 02-25-2025 | 05-02-2025 | 08-05-2025 | 11-05-2025 | 02-24-2026 | |
| Assets | |||||||||
| Total Assets | 105.849 B | 112.630 B | 117.532 B | 117.106 B | 115.122 B | 117.523 B | 129.546 B | 136.866 B | |
| Current Assets | 31.445 B | 38.205 B | 40.361 B | 38.782 B | 35.503 B | 37.065 B | 47.557 B | 43.516 B | |
| Inventories | 6.510 B | 6.469 B | 6.244 B | 6.109 B | 6.196 B | 6.601 B | 6.444 B | 6.658 B | |
| Other Current Assets | 7.950 B | 8.740 B | 8.143 B | 8.706 B | 9.289 B | 9.996 B | 10.779 B | 10.518 B | |
| Short Term Investments | 40.000 M | 50.000 M | 0.000 | 447.000 M | 599.000 M | 615.000 M | 45.000 M | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 5.579 B | 11.304 B | 14.593 B | 13.242 B | 8.629 B | 8.007 B | 18.169 B | 14.565 B | |
| Total Non-current Assets | 280.000 M | 357.000 M | 575.000 M | 463.000 M | 616.000 M | 774.000 M | 1.117 B | 956.000 M | |
| Property Plant Equipment | 23.045 B | 23.221 B | 23.446 B | 23.779 B | 24.793 B | 25.236 B | 25.639 B | 25.316 B | |
| Other Assets | 51.359 B | 51.204 B | 53.725 B | 54.545 B | 54.826 B | 55.222 B | 56.350 B | 68.034 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 105.849 B | 112.630 B | 117.532 B | 117.106 B | 115.122 B | 117.523 B | 129.546 B | 136.866 B | |
| Total liabilities | 65.425 B | 68.982 B | 72.972 B | 70.734 B | 66.722 B | 68.463 B | 77.639 B | 84.204 B | |
| Total current liabilities | 25.099 B | 26.060 B | 29.586 B | 28.420 B | 25.174 B | 26.037 B | 28.628 B | 28.327 B | |
| Accounts Payable | 3.514 B | 3.519 B | 3.586 B | 4.079 B | 3.784 B | 3.892 B | 4.147 B | 4.404 B | |
| Other liabilities | 8.262 B | 7.329 B | 7.540 B | 6.465 B | 6.655 B | 7.031 B | 7.661 B | 7.688 B | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 31.142 B | 34.717 B | 34.982 B | 34.462 B | 33.484 B | 33.968 B | 39.969 B | 46.750 B | |
| Other liabilities | 8.262 B | 7.329 B | 7.540 B | 6.465 B | 6.655 B | 7.031 B | 7.661 B | 7.688 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 40.364 B | 43.582 B | 44.502 B | 46.313 B | 48.335 B | 48.993 B | 51.850 B | 52.606 B | |
| Common stock | 46.386 B | 46.150 B | 46.318 B | 46.492 B | 46.604 B | 46.432 B | 46.620 B | 46.817 B | |
| Retained earnings | 56.697 B | 60.187 B | 61.384 B | 63.069 B | 66.097 B | 68.477 B | 72.231 B | 73.075 B |